Key facts
- This page summarizes Jack Phillips's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Apr 2024, 16:26.
Jack Phillips - 04 Apr 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- AXDX
- Reported as of
- 04 Apr 2024
- Net transaction value
- -$13,981
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2024, 16:26:25 UTC
- Prior SEC filing
- 06 Mar 2024
- Next SEC filing
- 16 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Patience, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jack Phillips filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 05 Apr 2024.
Change
- Previous filing in this sequence was filed on 06 Mar 2024.
- Current net transaction value: -$13,981.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXDX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +35,523
- Change %
- +46%
- Price
- $0.000000
- Shares after
- 112,230
- Date
- 04 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
AXDX
transaction
Common Stock
Sale
- Transaction value
- $13,981
- Shares
- -15,887
- Change %
- -14%
- Price
- $0.8800
- Shares after
- 96,343
- Date
- 04 Apr 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXDX
transaction
Derivative
Employee Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -35,523
- Change %
- -40%
- Price
- $0.000000
- Shares after
- 53,283
- Date
- 04 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,523
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
Footnote F2
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.